ClinicalTrials.govpublic full text
DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
brain cancer, central nervous system diseases, brain, cns, conditionally replication-competent adenovirus, delta-24-rgd, dnx-2401, recurrent malignant gliomas, malignant brain tumor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 978873
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.